Welcome to the Thrombosis.TV network. The Thrombosis.TV network brings the latest news, study updates,
and answers to frequently asked questions to our viewers. Explore key interviews with the
researchers themselves and ask questions of the author through our “Ask the Experts” feature.

In this program entitled “Managing DOAC-Related Bleeding: Putting Idarucizumab and Andexanet Data Into Practice," host Thomas Baldrick talks with Charles Pollack, M.D., lead author of the RE-VERSE AD study with idarucizumab for the reversal of dabigatran anticoagulation. Next, Beverley Hunt, M.D. joins her colleagues Saskia Middeldorp, M.D. and Alexander (Ander) T. Cohen, M.B.B.S., M.Sc., M.D., F.R.A.C.P. to discuss the issues associated with DOAC-related bleeding and its management, including new data from the ANNEXA study with andexanet alfa presented at ISTH 2017.

Thrombosis.TV is a leading destination for venous and arterial thrombosis education, news and expert opinion.
We combine a television background with the
latest science and insights to provide the latest
education. Working with our editorial board and
leading physicians in embolic disease, you will
find the most up to date information and important
educational tools